PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs

Objective: The aim of this study was to design and validate a questionnaire to measure perceived symptoms associated with antihypertensive drugs (PERSYVE). Methods: The PERSYVE development and validation included four stages: 1) item development (bibliographic review and questionnaire elaboration); 2) face and content validation; 3) field testing (pre-test); and 4) test-retest validation, assessment of internal consistency (Cronbach´s alpha) and reproducibility over time (intraclass correlation coefficient and Cohen´s kappa coefficient). Results: PERSYVE is divided into six sections according to results obtained from the literature review: (1) drug adherence, (2) perceived symptoms and how they affect quality of life (five-point Likert scale), (3) communication with health professionals, (4) perception of symptoms as adverse reactions, (5) influence on therapy compliance, and (6) adoption of non-pharmacological methods for blood pressure control. Content and face validation of the questionnaire led to some vocabulary changes and the introduction of section 2.1. Field-testing (n=26) revealed high comprehensibility of the questions. The Cronbach's alpha, calculated for section 2 (five-point Likert scale) was 0.850. PERSYVE was reproducible (n=167): kappa values presented fair to substantial reproducibility and, in section 2, ICC values resulted in good to excellent reproducibility. Conclusion: Results showed that PERSYVE is a well-structured, objective, patient-friendly, valid and reliable questionnaire. PERSYVE can be a very useful instrument in hypertensive patients´ monitoring and in the screening of adverse effects.

Saved in:
Bibliographic Details
Main Authors: Duarte-Silva,Daniela, Figueiras,Adolfo, Herdeiro,Maria T., Teixeira Rodrigues,António, Silva Branco,Fábio, Polónia,Jorge, Figueiredo,Isabel V.
Format: Digital revista
Language:English
Published: Centro de Investigaciones y Publicaciones Farmacéuticas 2014
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2014000200005
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1885-642X2014000200005
record_format ojs
spelling oai:scielo:S1885-642X20140002000052017-01-23PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugsDuarte-Silva,DanielaFigueiras,AdolfoHerdeiro,Maria T.Teixeira Rodrigues,AntónioSilva Branco,FábioPolónia,JorgeFigueiredo,Isabel V. Antihypertensive Agents Drug-Related Side Effects and Adverse Reactions Medication Adherence Questionnaires Validation Studies as Topic Portugal Objective: The aim of this study was to design and validate a questionnaire to measure perceived symptoms associated with antihypertensive drugs (PERSYVE). Methods: The PERSYVE development and validation included four stages: 1) item development (bibliographic review and questionnaire elaboration); 2) face and content validation; 3) field testing (pre-test); and 4) test-retest validation, assessment of internal consistency (Cronbach´s alpha) and reproducibility over time (intraclass correlation coefficient and Cohen´s kappa coefficient). Results: PERSYVE is divided into six sections according to results obtained from the literature review: (1) drug adherence, (2) perceived symptoms and how they affect quality of life (five-point Likert scale), (3) communication with health professionals, (4) perception of symptoms as adverse reactions, (5) influence on therapy compliance, and (6) adoption of non-pharmacological methods for blood pressure control. Content and face validation of the questionnaire led to some vocabulary changes and the introduction of section 2.1. Field-testing (n=26) revealed high comprehensibility of the questions. The Cronbach's alpha, calculated for section 2 (five-point Likert scale) was 0.850. PERSYVE was reproducible (n=167): kappa values presented fair to substantial reproducibility and, in section 2, ICC values resulted in good to excellent reproducibility. Conclusion: Results showed that PERSYVE is a well-structured, objective, patient-friendly, valid and reliable questionnaire. PERSYVE can be a very useful instrument in hypertensive patients´ monitoring and in the screening of adverse effects.Centro de Investigaciones y Publicaciones FarmacéuticasPharmacy Practice (Granada) v.12 n.2 20142014-06-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2014000200005en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Duarte-Silva,Daniela
Figueiras,Adolfo
Herdeiro,Maria T.
Teixeira Rodrigues,António
Silva Branco,Fábio
Polónia,Jorge
Figueiredo,Isabel V.
spellingShingle Duarte-Silva,Daniela
Figueiras,Adolfo
Herdeiro,Maria T.
Teixeira Rodrigues,António
Silva Branco,Fábio
Polónia,Jorge
Figueiredo,Isabel V.
PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs
author_facet Duarte-Silva,Daniela
Figueiras,Adolfo
Herdeiro,Maria T.
Teixeira Rodrigues,António
Silva Branco,Fábio
Polónia,Jorge
Figueiredo,Isabel V.
author_sort Duarte-Silva,Daniela
title PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs
title_short PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs
title_full PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs
title_fullStr PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs
title_full_unstemmed PERSYVE: design and validation of a questionnaire about adverse effects of antihypertensive drugs
title_sort persyve: design and validation of a questionnaire about adverse effects of antihypertensive drugs
description Objective: The aim of this study was to design and validate a questionnaire to measure perceived symptoms associated with antihypertensive drugs (PERSYVE). Methods: The PERSYVE development and validation included four stages: 1) item development (bibliographic review and questionnaire elaboration); 2) face and content validation; 3) field testing (pre-test); and 4) test-retest validation, assessment of internal consistency (Cronbach´s alpha) and reproducibility over time (intraclass correlation coefficient and Cohen´s kappa coefficient). Results: PERSYVE is divided into six sections according to results obtained from the literature review: (1) drug adherence, (2) perceived symptoms and how they affect quality of life (five-point Likert scale), (3) communication with health professionals, (4) perception of symptoms as adverse reactions, (5) influence on therapy compliance, and (6) adoption of non-pharmacological methods for blood pressure control. Content and face validation of the questionnaire led to some vocabulary changes and the introduction of section 2.1. Field-testing (n=26) revealed high comprehensibility of the questions. The Cronbach's alpha, calculated for section 2 (five-point Likert scale) was 0.850. PERSYVE was reproducible (n=167): kappa values presented fair to substantial reproducibility and, in section 2, ICC values resulted in good to excellent reproducibility. Conclusion: Results showed that PERSYVE is a well-structured, objective, patient-friendly, valid and reliable questionnaire. PERSYVE can be a very useful instrument in hypertensive patients´ monitoring and in the screening of adverse effects.
publisher Centro de Investigaciones y Publicaciones Farmacéuticas
publishDate 2014
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2014000200005
work_keys_str_mv AT duartesilvadaniela persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs
AT figueirasadolfo persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs
AT herdeiromariat persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs
AT teixeirarodriguesantonio persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs
AT silvabrancofabio persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs
AT poloniajorge persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs
AT figueiredoisabelv persyvedesignandvalidationofaquestionnaireaboutadverseeffectsofantihypertensivedrugs
_version_ 1755941137104764928